About XOMA Corporation
https://www.xoma.comXOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies.
CEO
Owen P. Hughes Jr.
Compensation Summary
(Year 2024)
Ratings Snapshot
Rating : B
Price Target
About XOMA Corporation
https://www.xoma.comXOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $9.35M ▼ | $9.8M ▲ | $14.15M ▲ | 151.31% ▲ | $0.74 ▲ | $17.4M ▲ |
| Q2-2025 | $13.13M ▼ | $7.87M ▼ | $9.19M ▲ | 70.01% ▲ | $0.46 ▲ | $13.09M ▲ |
| Q1-2025 | $15.91M ▲ | $8.69M ▼ | $2.37M ▲ | 14.88% ▲ | $0.06 ▼ | $6.48M ▲ |
| Q4-2024 | $8.71M ▲ | $24.77M ▲ | $-3.97M ▲ | -45.54% ▲ | $0.82 ▲ | $-6.02M ▲ |
| Q3-2024 | $7.2M | $22.84M | $-17.24M | -239.59% | $-1.59 | $-13.75M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $92M ▲ | $263.15M ▲ | $155.19M ▲ | $107.96M ▲ |
| Q2-2025 | $83.86M ▼ | $223.46M ▲ | $131M ▲ | $92.45M ▲ |
| Q1-2025 | $92.65M ▼ | $212.75M ▼ | $128.12M ▼ | $84.63M ▲ |
| Q4-2024 | $105.18M ▼ | $221.28M ▼ | $139.36M ▲ | $81.92M ▼ |
| Q3-2024 | $142.84M | $223.34M | $138.53M | $84.81M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $10.35M ▲ | $-296K ▼ | $58.21M ▲ | $-5.85M ▼ | $15.34M ▲ | $-296K ▼ |
| Q2-2025 | $6.89M ▲ | $6.39M ▲ | $-19.98M ▼ | $-2.95M ▲ | $-16.54M ▼ | $6.39M ▲ |
| Q1-2025 | $2.37M ▲ | $2.2M ▲ | $-6.69M ▲ | $-6.89M ▼ | $-11.39M ▲ | $2.2M ▲ |
| Q4-2024 | $-3.97M ▲ | $-2.9M ▲ | $-36.43M ▼ | $-1.07M ▲ | $-39.15M ▼ | $-2.91M ▲ |
| Q3-2024 | $-17.24M | $-8.7M | $9.52M | $-3.92M | $-1.77M | $-8.7M |
Revenue by Geography
| Region | Q2-2025 | Q3-2025 |
|---|---|---|
 Asia Pacific | $0 ▲ | $0 ▲ |
 SWITZERLAND | $10.00M ▲ | $10.00M ▲ |
 UNITED STATES | $10.00M ▲ | $0 ▼ |
CEO
Owen P. Hughes Jr.
Compensation Summary
(Year 2024)
Ratings Snapshot
Rating : B